AU2021903793A0 - Methods for the diagnosis and/or treatment of neuroendocrine cancers - Google Patents

Methods for the diagnosis and/or treatment of neuroendocrine cancers

Info

Publication number
AU2021903793A0
AU2021903793A0 AU2021903793A AU2021903793A AU2021903793A0 AU 2021903793 A0 AU2021903793 A0 AU 2021903793A0 AU 2021903793 A AU2021903793 A AU 2021903793A AU 2021903793 A AU2021903793 A AU 2021903793A AU 2021903793 A0 AU2021903793 A0 AU 2021903793A0
Authority
AU
Australia
Prior art keywords
diagnosis
treatment
methods
neuroendocrine cancers
neuroendocrine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021903793A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clarity Pharmaceuticals Ltd
Original Assignee
Clarity Pharmaceuticals Ltd
Filing date
Publication date
Application filed by Clarity Pharmaceuticals Ltd filed Critical Clarity Pharmaceuticals Ltd
Publication of AU2021903793A0 publication Critical patent/AU2021903793A0/en
Pending legal-status Critical Current

Links

AU2021903793A 2021-11-24 Methods for the diagnosis and/or treatment of neuroendocrine cancers Pending AU2021903793A0 (en)

Publications (1)

Publication Number Publication Date
AU2021903793A0 true AU2021903793A0 (en) 2021-12-09

Family

ID=

Similar Documents

Publication Publication Date Title
IL300147A (en) Piperidin-1-yl-n-pyryidine-3-yl-2- oxoacetamide derivatives useful for the treatment of mtap-deficient and/or mta-accumulating cancers
EP3894392A4 (en) Compositions and methods for the treatment of cancer
EP3580560A4 (en) Methods for the detection and treatment of lung cancer
EP3615056A4 (en) Methods and agents for the detection and treatment of cancer
EP3496721A4 (en) Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas
EP4048406A4 (en) Combination therapy for the treatment of solid and hematological cancers
EP3893902A4 (en) Models and methods useful for the treatment of serrated colorectal cancer
EP4034109A4 (en) Method and composition for the treatment of disease
EP3673267A4 (en) Methods of diagnosing and treating lung cancer
EP3852774A4 (en) Methods for diagnosis and treatment of type 1 diabetes
EP3820492A4 (en) Apmv and uses thereof for the treatment of cancer
EP4199961A4 (en) Combination immunotherapy methods for the treatment of cancer
EP4099988A4 (en) Rna-loaded nanoparticles and use thereof for the treatment of cancer
EP3826623A4 (en) Compositions and methods for the treatment of cancer characterized with pcsk9 expression
AU2021903793A0 (en) Methods for the diagnosis and/or treatment of neuroendocrine cancers
EP3762035A4 (en) Compositions and methods for the diagnosis and treatment of alt cancer
EP4192327A4 (en) Devices and methods for vascular navigation, assessment, treatment and/or diagnosis
IL286649A (en) Quinoline derivatives and their use for the treatment of cancer
EP3887405A4 (en) Compositions and methods for the treatment and/or prevention of her2+cancers
EP4100127A4 (en) Methods for the treatment of scleroderma and related conditions
EP3987032A4 (en) Methods and compositions for the treatment of cancer
EP4114411A4 (en) Compositions and methods for the treatment of pancreatic cancer
EP4031118A4 (en) Compositions and methods for the treatment of swi-snf mutant tumors
EP3973292A4 (en) Methods of diagnosing and treating cervical cancer
EP4004013A4 (en) Dinucleotide compounds for treating cancers and medical uses thereof